SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-011458
Filing Date
2018-05-08
Accepted
2018-05-08 07:10:17
Documents
3
Period of Report
2018-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K Q1 2018 EARNINGS RELEASE sgmo-8k_20180508.htm 8-K 30908
2 EX-99.1 sgmo-ex99_6.htm EX-99 136547
3 GRAPHIC g201805080125356291918.jpg GRAPHIC 25088
  Complete submission text file 0001564590-18-011458.txt   203431
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30171 | Film No.: 18812931
SIC: 2836 Biological Products, (No Diagnostic Substances)